rDEN2∆30-7169
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
Dengue
Phase 1
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
CompletedNCT02021968
Start: 2013-11-30End: 2015-12-31Updated: 2015-12-15
Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
CompletedNCT02317900
Start: 2014-12-31Target: 48Updated: 2017-02-01